β
ER-negative
Immune checkpoint
Invasive breast cancer
PD-L1
Tumor-infiltrating lymphocytes
β2-Adrenergic receptor
Journal
Breast cancer research and treatment
ISSN: 1573-7217
Titre abrégé: Breast Cancer Res Treat
Pays: Netherlands
ID NLM: 8111104
Informations de publication
Date de publication:
Oct 2019
Oct 2019
Historique:
received:
04
05
2019
accepted:
29
06
2019
pubmed:
11
7
2019
medline:
12
2
2020
entrez:
11
7
2019
Statut:
ppublish
Résumé
Antitumor immunity plays an important role in the progression of breast cancer. β β Although β β
Identifiants
pubmed: 31290053
doi: 10.1007/s10549-019-05341-6
pii: 10.1007/s10549-019-05341-6
doi:
Substances chimiques
Biomarkers
0
Receptors, Adrenergic, beta-2
0
Receptors, Estrogen
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
603-610Subventions
Organisme : Australian National Health and Medical Research Council
ID : APP1147498